Evaluation of the Clinical Utility of Circulating Tumor DNA in the Management of Patients With Nonmetastatic Head and Neck Cancer: Protocol for a Prospective Bicentric Study (CIRVAD)

Evaluation of the Clinical Utility of Circulating Tumor DNA in the Management of Patients With Nonmetastatic Head and Neck Cancer: Protocol for a Prospective Bicentric Study (CIRVAD)

Authors of this article:

Romina Mastronicola^{1, 2} ;   Maëlys Bresson¹ ;   Giacomo Gravante¹ ;   Sophie Cortese¹ ;   Emilie Beulque¹ ;   Fadila Chergui¹ ;   Alexandre Harlé¹ ;   Gilles Dolivet^{1, 2}